Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2006, Vol. 107, No. 2, pp. 473-479.
Prepublished online as a Blood First Edition Paper on September 22, 2005; DOI 10.1182/blood-2005-04-1754.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-04-1754v1
107/2/473    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vitale, A.
Right arrow Articles by Foà, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vitale, A.
Right arrow Articles by Foà, R.
Related Collections
Right arrow Neoplasia
Right arrow Clinical Trials and Observations
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CLINICAL TRIALS AND OBSERVATIONS

Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol

Antonella Vitale, Anna Guarini, Cristina Ariola, Marco Mancini, Cristina Mecucci, Antonio Cuneo, Fabrizio Pane, Giuseppe Saglio, Giuseppe Cimino, Agostino Tafuri, Giovanna Meloni, Francesco Fabbiano, Anna Recchia, Maria Grazia Kropp, Mauro Krampera, Nicola Cascavilla, Felicetto Ferrara, Antonio Romano, Patrizio Mazza, Claudio Fozza, Francesca Paoloni, Marco Vignetti, and Robin Foà

From the Department of Cellular Biotechnologies and Hematology, University "La Sapienza" Roma, Rome; Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia; Department of Biomedical Sciences and Advanced Therapy, University of Ferrara, Ferrara; CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, Federico II University, Naples; Department of Clinical and Biological Sciences, S. L. Gonzaga Hospital, Orbassano, University of Turin, Turin; Hematology, Hospital Cervello, Palermo; Hematology, Civil Hospital, Pescara; Hematology, Azienda Ospedaliera A. Pugliese, Catanzaro; Department of Clinical and Experimental Medicine, University of Verona, Verona; Hematology, Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo; Hematology, Cardarelli Hospital, Naples; Ospedale Regionale "A. Di Summa," Brindisi; Ospedale S. S. Annunziata, Taranto; University of Sassari, Sassari; and Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Data Center, Rome, Italy.

Between 1996 and 2000, 90 newly diagnosed adult patients with T-acute lymphoblastic leukemia (T-ALL) were registered in the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Leucemia Acuta Limfoide (LAL) 0496 protocol. Cases were centrally processed for morphology, immunophenotype, cytogenetics, molecular biology, and multidrug resistance (MDR). Twenty-two patients were females and 68 were males. Four percent of cases were pro-T, 47% pre-T, 39% cortical T, and 10% mature T-ALL. Fifty-six percent of patients with pro-T + pre–T-ALL achieved complete remission (CR) compared with 91% for cortical + mature cases (P = .002). CD34 expression was associated with a significantly lower CR rate: 54% versus 84% (P = .009). Thirty-one (36.5%) of 85 patients had an abnormal karyotype, the most common abnormality (15%) being a partial del(6q). The cytogenetic profile did not impact on CR achievement. MDR1 function, present in 26% of cases, correlated significantly with CR achievement (P = .004). A highly significant (P = .001) difference in CR rate was observed between patients who did not express the CD13/CD33/CD34 antigens and were MDR functionally negative (96%) compared with patients positive for at least one of these markers (57%). Multivariate analysis showed an impact on CR achievement for CD33 expression and MDR1 function. An extensive biologic workup of adult T-ALL cases at presentation is recommended in order to design tailored therapeutic strategies aimed at improving CR rates.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCOHome page
C. D. Baldus, P. Martus, T. Burmeister, S. Schwartz, N. Gokbuget, C. D. Bloomfield, D. Hoelzer, E. Thiel, and W. K. Hofmann
Low ERG and BAALC Expression Identifies a New Subgroup of Adult Acute T-Lymphoblastic Leukemia With a Highly Favorable Outcome
J. Clin. Oncol., August 20, 2007; 25(24): 3739 - 3745.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
S. Chiaretti, S. Tavolaro, E. M. Ghia, C. Ariola, C. Matteucci, L. Elia, R. Maggio, M. Messina, M. R. Ricciardi, A. Vitale, et al.
Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis
Haematologica, May 1, 2007; 92(5): 619 - 626.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. Vitale, A. Guarini, C. Ariola, G. Meloni, O. Perbellini, M. Pizzuti, C. De Gregoris, V. Mettivier, A. Pastorini, G. Pizzolo, et al.
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial
Haematologica, March 1, 2007; 92(3): 342 - 348.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
N. Gokbuget and D. Hoelzer
Treatment of Adult Acute Lymphoblastic Leukemia
Hematology, January 1, 2006; 2006(1): 133 - 141.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020